Expression profile of E‐cadherin, estrogen receptors, and P53 in early‐onset gastric cancers

Fan Zhou(Sichuan University), Qin Huang(People's Hospital of Xinjiang Uygur Autonomous Region), Jiong Shi(Nanjing Drum Tower Hospital), Lei Wang(Zhejiang Chinese Medical University), Yuanyuan Xu(Nanjing Drum Tower Hospital), Xing Lan(Xuzhou Medical College), Xiaoping Zou(Nanjing Drum Tower Hospital)
Cancer Medicine
October 25, 2016
10.1002/cam4.931
Cited by 31

Related Papers

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program
|Blood|2013|683
Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study
|Blood|2012|396
Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver.
|Journal of Biological Chemistry|1993|375
Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study
|Leukemia|2012|362
Immunohistochemical localization of the D1 dopamine receptor in rat brain reveals its axonal transport, pre- and postsynaptic localization, and prevalence in the basal ganglia, limbic system, and thalamic reticular nucleus.
|Proceedings of the National Academy of Sciences|1992|260